Jason Marshall Hannon Esq. — Advisor at NuVasive

Mr. Jason Marshall Hannon, Esq., has been the Chief Executive Officer of Mainstay Medical International plc since October 9, 2017. Mr. Hannon has been an Advisor of NuVasive, Inc. since September 1, 2017 and served as its President and Chief Operating Officer from September 11, 2016 to August 1, 2017. Mr. Hannon served as an Executive Vice President of International at NuVasive, Inc. since July 16, 2015 until September 11, 2016 and served as its General Counsel from January 2007 to December 1, 2015. He served as an Executive Vice President of Corporate Development at NuVasive, Inc. from January 1, 2010 to July 2015 and served as its Secretary from January 2007 to July 2015. Mr. Hannon served as Executive Vice President of NuVasive, Inc. since January 1, 2010 and served as its Senior Vice President from January 2007 to January 2009. He served as Senior Vice President of Corporate Development of NuVasive, Inc. from January 2009 to January 1, 2010. He served as Vice President of Legal Affairs at Nuvasive, Inc. from June 14, 2005 to January 2009 and was a Consultant since August 1, 2017 until September 1, 2017. Mr. Hannon was employed at Heller Ehrman LLP. Mr. Hannon served as a Law Clerk to the Honorable Jerome Farris of the U.S. Court of Appeals for the Ninth Circuit. Mr. Hannon practiced corporate and transactional law at the law firms of Brobeck Phleger & Harrison LLP. Mr. Hannon has broad medical device experience has spanned areas like critical commercialization of new products, penetration of new markets, product innovation, strategic and financial planning, raising capital, regulatory and clinical management and the building of a high-performance culture. He has been a Director of Mainstay Medical International plc since October 9, 2017. He served as a Director of Nemaris, Inc. Mr. Hannon holds a B.A. degree from the University of California at Berkeley and a J.D. from Stanford Law School.